aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Long-Term Investments (2015 - 2016)

Updated

aTYR PHARMA's Long-Term Investments was $4 million in Q4 2016, down 86.6% from $29.81 million a year earlier and down 61.3% from the prior quarter.

Analysis

aTYR PHARMA (ATYR) Long-Term Investments (2015 - 2016) Analysis & Trends

From Q2 2015 onward, aTYR PHARMA has reported Long-Term Investments for 7 quarters.

  • In earlier years, Long-Term Investments was $29.81 million in FY2015.
  • Compared with a year earlier, Long-Term Investments has declined for three straight quarters.
  • Per Business Quant data, ATYR's Long-Term Investments in the three quarters before Q4 2016 was $10.33 million (Q3 2016), $12.66 million (Q2 2016) and $25.56 million (Q1 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 266.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 297.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 1.56 Bn
10 aTYR PHARMA 16.67 Mn -276.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 4.00 Mn
Sep 30, 2016 10.33 Mn
Jun 30, 2016 12.66 Mn
Mar 31, 2016 25.56 Mn
Dec 31, 2015 29.81 Mn
Sep 30, 2015 28.01 Mn
Jun 30, 2015 44.74 Mn
API Access

aTYR PHARMA Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ATYR&period=max&api_key=YOUR_API_KEY